{
    "SPADE_N_13757": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13757",
            "Peptide Name": "Anisaxin-2S (cecropins; natural AMPs; UCLL1, marine parasitic nematode; invertebrates, animals; BBMm)",
            "Source": "Anisakis pegreffii",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SWLSKTWKKLENSGKKRIAEGIAIALKGGLR",
            "Sequence Length": 31,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3440.05,
            "PI": 10.66,
            "Hydrophobicity": -0.49,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Roncevic T, Gerdol M, Mardirossian M, MaleÅ¡ M, Cvjetan S, Benincasa M, Maravic A, Gajski G, Krce L, Aviani I, Hrabar J, Trumbic Z, Derks M, Pallavicini A, Weingarth M, Zoranic L, Tossi A, Mladineo I. 2022",
                    "Reference": "Acta Biomater. 2022 Apr 22:S1742-7061(22)00234-3. doi: 10.1016/j.actbio.2022.04.025.PubMed",
                    "Title": "Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption"
                }
            ],
            "Frequent Amino Acids": "KGL",
            "Absent Amino Acids": "CDFHMOPQUVY",
            "Basic Residues": 8,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 12,
            "Polar Residues": 16,
            "Positive Residues": 8,
            "Negative Residues": 2,
            "Net Charge": 6,
            "Comments": "APD analysis reveals this sequence is most similar (87.1%) toAnisaxin-1Mol formula: C156H267N45O41, Mol Wt: 3443.042; Mol Ex Coeff: 3440.077; GRAVY:   -0.494.Activity:  Active against E. coli ATCC, c.i., or c.i.2 (MIC 0.5-1 uM), K. pneumoniae ATCC, c.i., c.i.2 (MIC 0.25-1 uM), A. baumannii ATCC, c.i., or c.i.2. (MIC 0.25-0.5 uM), P. aeruginosa ATCC, c.i., or c.i.2 (MIC 1-8 uM), and S. aureus ATCC (MIC 4 uM), S-aureus c.i., or c.i.2 (MIC >64 uM). All MBC values are similar to MIC values, indicative of a bactericidal effect.Toxicity:  the concentration that reduced 50% viability of HPBMC >100 uM.  NO vidence for DNA damage.Structure:  the peptide (20 uM) became helical in 50% TFE or 10 mM SDS based on CD studies.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_24421",
                    "Similarity": 1.0,
                    "Sequence": "SWLSKTWKKLENSGKKRIAEGIAIALKGGLR"
                },
                {
                    "SPADE_ID": "SPADE_N_13758",
                    "Similarity": 0.967741935483871,
                    "Sequence": "SWLSKTWKKLENSGKKRIAEGIAIALKGGAR"
                },
                {
                    "SPADE_ID": "SPADE_UN_24422",
                    "Similarity": 0.967741935483871,
                    "Sequence": "SWLSKTWKKLENSGKKRIAEGIAIALKGGAR"
                }
            ]
        }
    }
}